These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 21713306)
1. Once fat was fat and that was that: our changing perspectives on adipose tissue. Ferris WF; Crowther NJ Cardiovasc J Afr; 2011; 22(3):147-54. PubMed ID: 21713306 [TBL] [Abstract][Full Text] [Related]
2. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes. González N; Moreno-Villegas Z; González-Bris A; Egido J; Lorenzo Ó Cardiovasc Diabetol; 2017 Apr; 16(1):44. PubMed ID: 28376896 [TBL] [Abstract][Full Text] [Related]
3. Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity. Goran MI; Alderete TL Nestle Nutr Inst Workshop Ser; 2012; 73():49-60; discussion p61-6. PubMed ID: 23128765 [TBL] [Abstract][Full Text] [Related]
4. Adult weight change in relation to visceral fat and liver fat at middle age: The Netherlands epidemiology of obesity study. Verkouter I; Noordam R; de Roos A; Lamb HJ; Rosendaal FR; van Heemst D; de Mutsert R Int J Obes (Lond); 2019 Apr; 43(4):790-799. PubMed ID: 30026588 [TBL] [Abstract][Full Text] [Related]
5. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Lafontan M; Girard J Diabetes Metab; 2008 Sep; 34(4 Pt 1):317-27. PubMed ID: 18550411 [TBL] [Abstract][Full Text] [Related]
6. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995 [TBL] [Abstract][Full Text] [Related]
7. Critical role of the mesenteric depot versus other intra-abdominal adipose depots in the development of insulin resistance in young rats. Catalano KJ; Stefanovski D; Bergman RN Diabetes; 2010 Jun; 59(6):1416-23. PubMed ID: 20299478 [TBL] [Abstract][Full Text] [Related]
8. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Hajer GR; van Haeften TW; Visseren FL Eur Heart J; 2008 Dec; 29(24):2959-71. PubMed ID: 18775919 [TBL] [Abstract][Full Text] [Related]
9. Concise review: adipocyte origins: weighing the possibilities. Majka SM; Barak Y; Klemm DJ Stem Cells; 2011 Jul; 29(7):1034-40. PubMed ID: 21544899 [TBL] [Abstract][Full Text] [Related]
10. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. de Souza CJ; Eckhardt M; Gagen K; Dong M; Chen W; Laurent D; Burkey BF Diabetes; 2001 Aug; 50(8):1863-71. PubMed ID: 11473050 [TBL] [Abstract][Full Text] [Related]
11. Adipose Y5R mRNA is higher in obese than non-obese humans and is correlated with obesity parameters. Chatree S; Sitticharoon C; Maikaew P; Uawithya P; Chearskul S Exp Biol Med (Maywood); 2018 May; 243(9):786-795. PubMed ID: 29763369 [TBL] [Abstract][Full Text] [Related]
12. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects. Viljanen AP; Lautamäki R; Järvisalo M; Parkkola R; Huupponen R; Lehtimäki T; Rönnemaa T; Raitakari OT; Iozzo P; Nuutila P Ann Med; 2009; 41(2):152-60. PubMed ID: 18855190 [TBL] [Abstract][Full Text] [Related]
13. What Can We Learn from Interventions That Change Fat Distribution? Pramyothin P; Karastergiou K Curr Obes Rep; 2016 Jun; 5(2):271-81. PubMed ID: 27055863 [TBL] [Abstract][Full Text] [Related]
15. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Goossens GH Physiol Behav; 2008 May; 94(2):206-18. PubMed ID: 18037457 [TBL] [Abstract][Full Text] [Related]
16. Endothelial and Perivascular Adipose Tissue Abnormalities in Obesity-Related Vascular Dysfunction: Novel Targets for Treatment. Schinzari F; Tesauro M; Cardillo C J Cardiovasc Pharmacol; 2017 Jun; 69(6):360-368. PubMed ID: 28141700 [TBL] [Abstract][Full Text] [Related]
17. Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update. Piché ME; Poirier P; Lemieux I; Després JP Prog Cardiovasc Dis; 2018; 61(2):103-113. PubMed ID: 29964067 [TBL] [Abstract][Full Text] [Related]